Onward Therapeutics Announces IMPD Approval for NK Therapy
22 Apr 2025 //
PR NEWSWIRE
Emercell and Cell-Easy Sign Strategic Agreement for Scale-Up of NK-001
03 Oct 2022 //
CONTRACTPHARMA
22 Apr 2025 //
PR NEWSWIRE
03 Oct 2022 //
CONTRACTPHARMA